FROM REFUGEE TO RECEIVING MULTIPLE ACCOLADES AS A COMMUNITY PHARMACIST
With
Sara Murdock MPS,
Lead Pharmacist,
Pharmacy 777 Pascoe Vale (Melbourne), Victoria
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Melbourne | December 2025
Sara is an experienced pharmacist, community health advocate, and the Lead Pharmacist at Pharmacy 777 Pascoe Vale in Victoria. With over 20 years in the profession, Sara has played a significant role in advancing local healthcare delivery through clinical leadership, service development, and strong community partnerships.
In 2025, Sara was recognised as the VIC Pharmacist of the Year by the Pharmaceutical Society of Australia and the National Winner of the Outstanding Community Pharmacist Award by Patients Australia. Recently, Sara also was awarded the 2025 International Pharmacist of the Year by the Pharmacy Innovation Assembly, are acknowledgements that reflect her growing impact across pharmacy practice.
Sara is a passionate advocate for accessible healthcare, full scope pharmacy practice, and inclusive community services. She has led major health initiatives, including school-based immunisation programs, chronic disease prevention efforts, aged care outreach, and student mentoring programs. She also established the first pharmacist-led vaccination clinic at the local neighbourhood house, expanding care to vulnerable and underserved populations.
Beyond the dispensary, Sara is a key contributor to the national Pharmacy 777 Retail Services Pharmacy Owners Working Group. She collaborates on strategies for patient-centric care, retail innovation, and sustainable business models that support both pharmacists and consumers across Australia.
Her leadership also extends far beyond the pharmacy walls. Sara is an active Rotarian and Chair of Community Services for her local Rotary Club. She is a trusted speaker at Rotary events, parliamentary forums, health panels, universities, and grassroots community gatherings, bringing both lived experience and professional expertise to the conversation.
As a solo mother of two and a dedicated health professional, Sara brings compassion, experience, and clarity of purpose to her work. She is especially committed to supporting the next generation of pharmacists and advocating for systems that deliver better outcomes for patients and communities alike.
Sara’s voice is one of resilience. At just 12 years old, she was smuggled from war-tom Iraq through mountains and borders, arriving in Australia as a child refugee. Her early experiences shaped her enduring belief in equitable healthcare and the power of service, Today, she continues to build a career and legacy rooted in care, contribution, and connection, proving that it’s possible to lead with strength while remaining grounded in humanity.
Source: Supplied and adapted
-
Specialist physiotherapist successfully mixes online & in-person
Dr. Kieran Richardson (FACP) is a Specialist Physiotherapist, conferred by the Australian College of Physiotherapists (Australian Physiotherapy Association) in 2016. Dr Richardson is the Director of Global Specialist Physiotherapy, a consultancy company providing online Formal Mentoring and Professional Development individual clinicians, clinics, and groups, as well as Second Opinions to clinicians and directly to patients all around the world.
-
Landmark brain shape study
For over a century, researchers have thought that the patterns of brain activity that define our experiences, hopes and dreams are determined by how different brain regions communicate with each other through a complex web of trillions of cellular connections.
Now, a Monash University Turner Institute for Brain and Mental Health-led study has examined more than 10,000 different maps of human brain activity and found that the overall shape of a person’s brain exerts a far greater influence on how we think, feel and behave than its intricate neuronal connectivity.
-
Maximising benefits, minimising harms in population health screening
Population screening is an important contributor to advancing health outcomes through the early detection of and successful intervention for chronic disease. The evolution of science, technology and evidence relating to diseases which are or may be amenable to a population screening approach deserve broad discussion and the sharing of expertise and evidence. They also warrant close scrutiny in context of health policy and health resource allocation considerations.
In March, Public Health Association of Australia (PHAA) convened Screening Conference Conference 2025 with the theme of ‘Population Screening for Chronic Disease – Maximising Benefits, Minimising Harms’.
